Lyon与Milan评分联合预测胃食管反流病管理结局优于任一评分单独或各组分
研究纳入九中心532例接受高分辨率测压和pH-阻抗监测的连续患者,探索Lyon与Milan评分的关系及联合预测临床结局的能力。临床改善定义为总体症状减少50%。两评分一致阳性时改善率89%,不一致时63%,均阴性时19%(p<0.001)。Lyon与Milan评分的ROC曲线下面积分别为0.790和0.835,优于DeMeester评分(0.736)和酸暴露时间(0.741)。
要点
- Lyon与Milan评分一致阳性者临床改善率89%,均阴性者仅19%。
- Milan评分ROC曲线下面积0.835,Lyon评分0.790,均优于酸暴露时间0.741。
- 两评分联合可优化预测准确性,指导治疗升级。
核心结论
- Lyon与Milan评分在预测胃食管反流病患者结局方面优于酸暴露时间和DeMeester评分。
- 两评分一致时提供最佳预测准确性,可指导治疗升级。
研究设计与样本
- 多中心研究,收集九个中心连续接受高分辨率测压和pH-阻抗监测患者的临床与随访数据,共532例(女性50.6%,年龄50岁)。
- 临床改善定义为总体症状减少50%。
主要发现
- 532例中47.7%为病理性胃食管反流病。
- Lyon表型中Milan评分呈阶梯式升高。
- 63例接受手术治疗,131例接受药物治疗。
- Lyon表型结论性和严重者的临床改善率分别为81%和83%;Milan分类非常可能和极可能者分别为88.5%和100%。
- Lyon与Milan评分均阳性时改善率89%,不一致时63%,均阴性时19%(p<0.001)。
关键数值与推荐
- 临床改善定义为总体症状减少50%。
- Lyon表型结论性改善率81%,严重者83%。
- Milan分类非常可能者改善率88.5%,极可能者100%。
- 两评分均阳性改善率89%,不一致63%,均阴性19%(p<0.001)。
- Lyon评分AUC 0.790,Milan评分AUC 0.835,DeMeester评分AUC 0.736,酸暴露时间AUC 0.741。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Confidence in gastro-oesophageal reflux disease (GERD) diagnosis is crucial to improve outcomes from escalation of treatment. The Lyon score phenotypes patients through endoscopy and pH-impedance (MII-pH). The Milan score quantifies antireflux barrier through high-resolution manometry (HRM) parameters. AIM: To explore the relationship between the Lyon and Milan scores and their combined performance in predicting clinical outcomes. METHODS: We collected clinical and follow-up data of consecutive patients with HRM and MII-pH from nine centres. Clinical improvement was defined as a 50% reduction in global symptoms. The relationship between Lyon and Milan scores and the rate of patients improved in Lyon phenotypes and Milan categories were explored. The ability of the Lyon, Milan, DeMeester scores and acid exposure time (AET) in predicting outcomes was assessed through receiver operating characteristics (ROC) analysis. RESULTS: Among 532 patients (50.6% female, age 50 years), 47.7% had pathologic GERD. A stepwise increase in the Milan score in Lyon phenotypes was observed. Sixty-three patients had surgical treatment, and 131 medical. Clinical improvement in Lyon phenotypes Conclusive and Severe was 81% and 83%; in Milan categories very likely and extremely likely was 88.5% and 100%. If Lyon and Milan scores were positive, improvement was 89%; if discordant, 63%; if both negative, 19% (p < 0.001). ROC analysis showed an AUC of 0.790 for Lyon score, 0.835 for Milan score, 0.736 for DeMeester score and 0.741 for AET. CONCLUSIONS: The Lyon and Milan scores outperformed AET and DeMeester scores in predicting outcomes in GERD patients. When concordant, they provide optimal predictive accuracy, guiding escalation of therapy.
引用
- Siboni S, Sozzi M, Visaggi P, et al. Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components. Aliment Pharmacol Ther. 2025. PMID: 40541561. doi:10.1111/apt.70245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。